These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17458288)

  • 1. [Pharmacological therapeutics for the metabolic syndrome].
    Katayama S
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():594-8. PubMed ID: 17458288
    [No Abstract]   [Full Text] [Related]  

  • 2. [New evidences guide the clinical practice in the prevention and treatment of cardiovascular disease].
    Hu DY
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2809-11. PubMed ID: 16324331
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
    Ginsberg HN; Stalenhoef AF
    J Cardiovasc Risk; 2003 Apr; 10(2):121-8. PubMed ID: 12668909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of nonalcoholic fatty liver disease.
    Targher G; Bellis A; Fornengo P; Ciaravella F; Pichiri I; Cavallo Perin P; Trimarco B; Marchesini G
    Dig Liver Dis; 2010 May; 42(5):331-40. PubMed ID: 20207207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of metabolic syndrome: statins.
    Xydakis AM; Ballantyne CM
    Endocrinol Metab Clin North Am; 2004 Sep; 33(3):509-23, vi. PubMed ID: 15262294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma: its role in metabolic syndrome.
    Pakala R; Kuchulakanti P; Rha SW; Cheneau E; Baffour R; Waksman R
    Cardiovasc Radiat Med; 2004; 5(2):97-103. PubMed ID: 15464947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integrated drug therapy of the metabolic syndrome].
    Julius U; Hanefeld M
    Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
    [No Abstract]   [Full Text] [Related]  

  • 8. Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention.
    Towfighi A; Ovbiagele B
    Cerebrovasc Dis; 2008; 26(2):106-12. PubMed ID: 18560212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dyslipidemia and metabolic syndrome].
    Darioli R; Perdrix J; Mooser V
    Rev Med Suisse Romande; 2002 May; 122(5):223-6. PubMed ID: 12094498
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.
    Grundy SM
    Nat Rev Drug Discov; 2006 Apr; 5(4):295-309. PubMed ID: 16582875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins].
    Kobayashi J
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():618-21. PubMed ID: 17458292
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of metabolic syndrome].
    Magyar Diabetes Társaság Metabolikus Munkacsoportja
    Orv Hetil; 2003 Jun; 144(23):1145-52. PubMed ID: 12858647
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin resistance as the basis of metabolic syndrome].
    Egorova EG
    Eksp Klin Gastroenterol; 2007; (1):8-13. PubMed ID: 17547106
    [No Abstract]   [Full Text] [Related]  

  • 15. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension: a new perspective in therapy and metabolic effect. Part I.
    Medina Ruiz A
    Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome: diabetes and cardiovascular disease.
    Gupta S; Gupta BM
    Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.
    Gazzaruso C; Bruno R; Garzaniti A; Giordanetti S; Fratino P; Sacchi P; Filice G
    J Hypertens; 2003 Jul; 21(7):1377-82. PubMed ID: 12817187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.